Uppdrag | 19 Jul 2023
Setterwalls has assisted Priveq Investment with an investment in FrostPharma
Setterwalls has assisted Priveq Investment with the acquisition of a majority stake in the speciality pharma company FrostPharma AB
FrostPharma is a speciality pharma company specialised in the commercialization of value-adding medicines and climate impact healthcare consumables. Since the start of the company in 2017, FrostPharma has launched over 50 products and developed its own product portfolio of hazardous waste containers under the brand WoodSafe.
For more information, please see Priveq Investment’s press release here.
Contact:
Mattias Detterfelt, Frida Lindhvall, Elin Sahlin, Rolf Larsson, Sophia Spala, Angelica Ström, Daniel Nilsson, Rebecka Norell, Alexandra Åberg
Practice areas: